Innate Pharma Reports Total Shares Outstanding and Voting Rights as of December 31, 2025

Innate Pharma reports a total of 93,719,323 ordinary shares and 6,324 Preferred Shares 2016, 7,581 Preferred Shares 2017 as of December 31, 2025. The total number of theoretical voting rights is 94,484,443, while the total number of exercisable voting rights is 94,465,868. The shares held in treasury by the Company are excluded from the exercisable voting rights.